Published in Eur J Health Econ on August 08, 2009
Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective? Antimicrob Agents Chemother (2012) 1.09
Economical analysis on prophylaxis, diagnosis, and treatment of periprosthetic infections. Open Orthop J (2013) 0.78
Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med (2010) 7.83
Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ (2005) 4.40
Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol (2006) 3.53
Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs: a randomized controlled trial. JAMA (2002) 3.42
Value based pricing for NHS drugs: an opportunity not to be missed? BMJ (2008) 3.33
Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol (2004) 2.88
Using value of information analysis to prioritise health research: some lessons from recent UK experience. Pharmacoeconomics (2006) 2.59
A systematic review highlights threats to validity in studies of barriers to cancer trial participation. J Clin Epidemiol (2007) 2.20
Impact of presumed consent for organ donation on donation rates: a systematic review. BMJ (2009) 2.07
The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia. AIDS (2008) 1.81
Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6. Med Decis Making (2012) 1.81
Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). Eur J Pain (2008) 1.76
Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6. Value Health (2012) 1.76
Pressure relieving support surfaces (PRESSURE) trial: cost effectiveness analysis. BMJ (2006) 1.75
Catalogue of EQ-5D scores for the United Kingdom. Med Decis Making (2011) 1.73
Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study. BMJ (2009) 1.72
Deconstructing media coverage of trastuzumab (Herceptin): an analysis of national newspaper coverage. J R Soc Med (2008) 1.57
Dangerous omissions: the consequences of ignoring decision uncertainty. Health Econ (2011) 1.42
Increasing participation of cancer patients in randomised controlled trials: a systematic review. Trials (2006) 1.41
150 years of caring--a brief history of Mississippi State Hospital. J Miss State Med Assoc (2005) 1.38
Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3). J Am Coll Cardiol (2005) 1.31
Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models. Health Econ (2005) 1.30
A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep Med Rev (2009) 1.20
Translating research into practice in Leeds and Bradford (TRiPLaB): a protocol for a programme of research. Implement Sci (2010) 1.05
Navigating uncharted waters? How international experience can inform the funding of mental health care in England. J Ment Health (2011) 1.04
The impact of trial baseline imbalances should be considered in systematic reviews: a methodological case study. J Clin Epidemiol (2007) 1.02
Palliative thoracic radiotherapy for non-small-cell lung cancer: a systematic review. Am J Clin Oncol (2003) 1.00
Pathology, diagnosis, and classification of pressure ulcers: comparing clinical and imaging techniques. Wound Repair Regen (2005) 0.94
Skin alterations of intact skin and risk factors associated with pressure ulcer development in surgical patients: a cohort study. Int J Nurs Stud (2006) 0.91
Exclusion of elderly persons from health-risk behavior clinical trials. Prev Med (2006) 0.91
Trastuzumab for the treatment of HER2-positive metastatic gastric cancer : a NICE single technology appraisal. Pharmacoeconomics (2013) 0.89
Bridging the gap between methods research and the needs of policy makers: a review of the research priorities of the National Institute for Health and Clinical Excellence. Int J Technol Assess Health Care (2011) 0.89
A cost-utility analysis of tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence. BJOG (2003) 0.88
The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments. Pharmacoeconomics (2010) 0.88
Using value of information analysis to inform publicly funded research priorities. Appl Health Econ Health Policy (2005) 0.86
Effects of a booster seat education and distribution program in child care centers on child restraint use among children aged 4 to 8 years. Arch Pediatr Adolesc Med (2009) 0.86
Methodological issues in undertaking independent cost-effectiveness analysis for NICE: the case of therapies for ADHD. Eur J Health Econ (2007) 0.86
Identifying research priorities: the value of information associated with repeat screening for age-related macular degeneration. Med Decis Making (2008) 0.85
An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome. Int J Technol Assess Health Care (2009) 0.84
Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndrome. Value Health (2009) 0.83
Glycopeptide vs. non-glycopeptide antibiotics for prophylaxis of surgical site infections: a systematic review. Surg Infect (Larchmt) (2010) 0.82
Immediate versus sustained effects: interrupted time series analysis of a tailored intervention. Implement Sci (2013) 0.82
Exploring the feasibility of Conjoint Analysis as a tool for prioritizing innovations for implementation. Implement Sci (2013) 0.82
Assessing generalisability in model-based economic evaluation studies: a structured review in osteoporosis. Pharmacoeconomics (2006) 0.82
Challenges in identifying barriers to adoption in a theory-based implementation study: lessons for future implementation studies. BMC Health Serv Res (2012) 0.81
Psychosocial interventions for non-professional carers of people with Parkinson's disease: a systematic scoping review. J Adv Nurs (2008) 0.80
Guidelines for treatment of upper gastrointestinal cancer. Lancet (2003) 0.80
Opportunities for improving the efficiency of paediatric HIV treatment programmes. AIDS (2015) 0.79
Costs of an early intervention versus a conservative strategy in acute coronary syndrome. Int J Cardiol (2007) 0.78
Unfinished symphony: a tribute to the life and career of Bernie O'Brien (1959-2004). Med Decis Making (2004) 0.75
The cost-effectiveness of different chemotherapy strategies for patients with poor prognosis advanced colorectal cancer (MRC FOCUS). Value Health (2011) 0.75
State Injury Programs' Response to the Opioid Epidemic: The Role of CDC's Core Violence and Injury Prevention Program. J Public Health Manag Pract (1) 0.75
Better analysis for better decisions: facing up to the challenges. Pharmacoeconomics (2006) 0.75
Connecting the Dots: State Health Department Approaches to Addressing Shared Risk and Protective Factors Across Multiple Forms of Violence. J Public Health Manag Pract (1) 0.75